These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39309905)

  • 61. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
    Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
    Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS; Kissick H; Ogan K; Harris WB; Carthon BC; Kucuk O; Master VA; Bilen MA
    Oncologist; 2021 May; 26(5):397-405. PubMed ID: 33634507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
    Kikuchi K; Nakamura R; Segawa T; Oikawa H; Ariga H
    J Radiat Res; 2020 Jul; 61(4):616-621. PubMed ID: 32567660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110).
    Boukovala M; Modest DP; Ricard I; Fischer von Weikersthal L; Decker T; Vehling-Kaiser U; Uhlig J; Schenk M; Freiberg-Richter J; Peuser B; Denzlinger C; Peveling Genannt Reddemann C; Graeven U; Schuch G; Schwaner I; Heinrich K; Neumann J; Jung A; Held S; Stintzing S; Heinemann V; Michl M
    ESMO Open; 2024 May; 9(5):103374. PubMed ID: 38744100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
    Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
    Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The inflammation-based modified Glasgow prognostic score is associated with survival in stable heart failure patients.
    Cho A; Arfsten H; Goliasch G; Bartko PE; Wurm R; Strunk G; Hülsmann M; Pavo N
    ESC Heart Fail; 2020 Apr; 7(2):654-662. PubMed ID: 32096921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score.
    Draeger DL; Groh S; Buchholz T; Woehl M; Nolting J; Hakenberg OW
    Urol Int; 2023; 107(5):489-495. PubMed ID: 34610603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 70. Evaluation of Five Prognostic Scores in Patients Receiving Chemoradiation for Primary Glioblastoma Multiforme.
    Zemskova O; Yu NY; Löser A; Leppert J; Rades D
    In Vivo; 2024; 38(4):1806-1813. PubMed ID: 38936935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma.
    Ni XC; Yi Y; Fu YP; He HW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
    Medicine (Baltimore); 2015 Sep; 94(36):e1486. PubMed ID: 26356714
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The combination of hand grip strength and modified Glasgow prognostic score predicts clinical outcomes in patients with liver cancer.
    Chen Y; Ruan GT; Shi JY; Liu T; Liu CA; Xie HL; Song MM; Wang ZW; Hu CL; Zhang HY; Zhang XW; Tian HY; Ge YZ; Yang M; Liu YY; Lin SQ; Liu XY; Zheng X; Wang KH; Cong MH; Shen X; Wang X; Deng L; Shi HP
    Front Nutr; 2023; 10():1062117. PubMed ID: 36923698
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Cui C; Wu X; Deng L; Wang W; Cui W; Wang Y
    Thorac Cancer; 2022 Jul; 13(14):2041-2049. PubMed ID: 35624549
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preoperative change of modified Glasgow prognostic score after stenting predicts the long-term outcomes of obstructive colorectal cancer.
    Sato R; Oikawa M; Kakita T; Okada T; Abe T; Yazawa T; Tsuchiya H; Akazawa N; Sato M; Ohira T; Harada Y; Okano H; Ito K; Ohuchi N; Tsuchiya T
    Surg Today; 2020 Mar; 50(3):232-239. PubMed ID: 31407166
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The modified Glasgow prognostic score in Crohn's disease-does it predict short-term outcome?
    Argeny S; Stift A; Bergmann M; Mittlböck M; Maschke S; Riss S
    Eur Surg; 2018; 50(4):177-182. PubMed ID: 31497036
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
    Jiang X; Hiki N; Nunobe S; Kumagai K; Kubota T; Aikou S; Sano T; Yamaguchi T
    Br J Cancer; 2012 Jul; 107(2):275-9. PubMed ID: 22713657
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.
    Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS; Kissick H; Ogan K; Nazha B; Carthon BC; Kucuk O; Harris WB; Master VA; Bilen MA
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.